Advanced Filters
noise

Barrett's Esophagus Clinical Trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 349 clinical trials

E Elly Goldstein

Using Natural Language Processing to Identify Depression in Patients with HIV

The purpose of this study is to develop algorithms that may help detect depressive symptoms in social media posts, specifically among men who have sex with men and who have HIV.

18-99 years Male Phase N/A
J JONNIE HANDSCHIN

Generation Study

The Generation study is a clinical research study for individuals ages 60 to 75 with an increased genetic risk of developing clinical symptoms of Alzheimer’s disease. The study is enrolling persons who have two copies of the APOE4 gene An employee of the investigative site or an immediate family member …

99 years and younger All Phase 2
K Kathlyn Schumacher

Randomized Controlled Trial Examining the Effects of Meal Timing Among Obese Individuals

Normal 0 false false false EN-US X-NONE X-NONE We are currently screening for this study, but all in-person visits are on hold until the COVID-19 virus state of emergency is lifted. The timing of food consumption is now recognized as a significant contributor to body weight regulation and metabolic functioning. …

21-50 years All Phase N/A
T THOMAS KANE

Legionella Pneumonia's Effect on Olfactory Function

The goal of this study is to determine whether those who have had Legionnaires' disease suffer smell loss.

18-99 years All Phase N/A
P Penn Presbyterian Medical Center

Exploratory Study of Mavacamten (MYK-461) in Patients with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (nHCM) and Preserved Left Ventricular Ejection Fraction

The purpose of this study is to compare the effect of the investigational drug, mavacamten, (MYK-461), to a placebo (an inactive substance) in patients with Non-obstructive Hypertrophic Cardiomyopathy (nHCM).

18-99 years All Phase 2
B Bhagyavati Hatwar

Low-Dose Naltrexone to Improve Physical Health in Patients with Vasculitis (LoDoNaVasc)

The purpose of this study is to see whether a drug called naltrexone improves health-related quality of life in patients with vasculitis. Naltrexone is a prescription drug approved for a different reason at a higher dose than the dose used in this study. However, “low dose naltrexone” is widely used, …

18-90 years All Phase 2
H Helene Chesnais

MRI Quantification of Hip Bone Microstructure in Stage 4 and 5 Chronic Kidney Disease

University of Pennsylvania Department of Radiology is conducting a research study on hip bone microstructure and strength in people with AND without chronic renal disease. The purpose of this research is to examine the microstructure of bone in the hip using a new, MRI-based approach.

21-50 years All Phase N/A
J JULIE STARR

TRaCkLIGHT study for people with moderate to severe Crohn's Disease

Patients with moderate to severe Crohn's disease, who have failed prior treatment with the standard anti-TNF therapy will receive the study medication - MDGN-002 - which may help treat the Crohn's disease and relieve its symptoms.

18-75 years All Phase 1
P Penn Presbyterian Medical Center

Mechanisms for Individual Differences in Hypertension in Obstructive Sleep Apnea

The purpose of this study is to compare the response to PAP treatment of patients with Obstructive Sleep Apnea (OSA) who have normal blood pressure to those with treated (that is taking medication or on a special diet) high blood pressure.

18-75 years All Phase N/A
P Penn Presbyterian Medical Center

A Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis

You are invited to take part in this research project. This is because you have a disease of the liver called Primary Biliary Cholangitis (sometimes referred to as Primary Biliary Cirrhosis). The purpose this study is to test a new treatment for this condition called Saroglitazar magnesium.

18-75 years All Phase 2

Simplify language using AI